Zdrowie i gospodarka · 26/06/2023
FDA Releases Draft Guidance for Clinical Investigations of Psychedelic Drugs
The FDA has announced the availability of a draft guidance for industry on the clinical investigations of psychedelic drugs, aiming to provide foundational considerations for sponsors developing these compounds for medical conditions.